Stay updated on Mylan Insulin Glargine Safety Clinical Trial

Sign up to get notified when there's something new on the Mylan Insulin Glargine Safety Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Mylan Insulin Glargine Safety Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.3, replacing Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T14:48:49.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added. The previous revision (v3.4.1) with funding and operating-status notices was removed.
    Difference
    0.3%
    Check dated 2026-02-11T01:57:43.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A government funding notice was added and the revision version updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-03T23:04:08.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added a 'Show glossary' option and updated footer metadata to 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', while removing 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.
    Difference
    0.2%
    Check dated 2026-01-27T22:56:09.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.3.4, replacing the previous Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-13T19:13:12.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added a Locations section and included state listings (California, Colorado, Florida, Georgia, Idaho, Illinois, Iowa, Texas); removed the individual California, Colorado, Florida, Georgia, Idaho, Illinois, Iowa, and Texas Location subsections. The page revision was updated to v3.3.3 (replacing v3.3.2) and the HHS Vulnerability Disclosure link was removed.
    Difference
    0.8%
    Check dated 2025-12-23T08:26:02.000Z thumbnail image

Stay in the know with updates to Mylan Insulin Glargine Safety Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Mylan Insulin Glargine Safety Clinical Trial page.